← Back to patent-cliff list
Allylestrenol
Tier C — Watch / tradeAllylestrenol
Gedeon Richter Ltd
Originator
1996
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：PR
Indications (approved)：产科分娩（早产）, Benign prostatic hyperplasia
Regional status
US
-
EU
-
China
Approved
2002-06-03
Japan
Approved
1996-01-23
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Allylestrenol?
Approved indications include: 产科分娩（早产）, Benign prostatic hyperplasia.
When does the Allylestrenol patent expire?
No public expiry year is available for Allylestrenol yet; this page updates once verified.
How do I get a quote for Allylestrenol intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-04